SGH
GSK icon

Sivik Global Healthcare’s GSK GSK Stock Holding History

Sivik Global Healthcare’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-100,000
Closed -$5.39M – 58
2016
Q3 		$5.39M Buy
100,000
+20,000
+25% +$1.1M 2.72% 17
2016
Q2 		$4.33M Buy
+80,000
New +$4.21M 2.15% 18

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sivik Global Healthcare's GSK Position: Q4 2016 in Review

Sivik Global Healthcare sold out of GSK (GSK) in Q4 2016, closing a stake of 100,000 shares — an estimated $5.39M sold.

Sivik Global Healthcare first reported a position in GSK in Q2 2016 and held it in 2 quarters. The position peaked at $5.39M in Q3 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Sivik Global Healthcare reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Sivik Global Healthcare sold 100,000 GSK shares in Q4 2016, an estimated $5.39M.
  • Sivik Global Healthcare first reported a position in GSK in Q2 2016 and held it in 2 quarters.
  • Sivik Global Healthcare's GSK position peaked at $5.39M in Q3 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Sivik Global Healthcare's 13F filing for Q4 2016, filed 13 Feb 2017.